Dihydropyridines: evaluation of their current and future pharmacological applications

被引：260

作者：

Edraki, Najmeh ^{[1
]}

Mehdipour, Ahmad R. ^{[1
]}

Khoshneviszadeh, Mehdi ^{[1
]}

Miri, Ramin ^{[1
]}

机构：

[1] Shiraz Univ Med Sci, Med & Nat Prod Chem Res Ctr, Shiraz, Iran

来源：

DRUG DISCOVERY TODAY | 2009年 / 14卷 / 21-22期

关键词：

CALCIUM-CHANNEL ANTAGONIST; P-GLYCOPROTEIN INHIBITORS; MULTIDRUG-RESISTANCE; CA2+ CHANNEL; IN-VIVO; 1,4-DIHYDROPYRIDINE DERIVATIVES; GENETIC ALGORITHM; VERTEBRATE CELLS; DELIVERY-SYSTEM; BLOCKERS;

D O I：

10.1016/j.drudis.2009.08.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The 1,4-dihydropyridines (DHPs), a class of drugs, possess a wide variety of biological and pharmacological actions, have represented one of the most important groups of calcium-channel-modulating agents and have experienced widespread use in the treatment of cardiovascular disease. Moreover, it has been demonstrated that DHPs could prove to be highly important as multidrug-resistance-reversing agents in cancer chemotherapy. Recent reports suggest that this class also has other notable activities, particularly as antimycobacterial and anticonvulsant agents. Finally, it might be possible for the DHP motif to serve as a scaffold for other pharmacological applications.

引用

页码：1058 / 1066

页数：9

共 81 条

[1]

[Anonymous], 2002, CALAMUS RENASCENS

[2] CLASSES OF CALCIUM CHANNELS IN VERTEBRATE CELLS [J].

BEAN, BP .

ANNUAL REVIEW OF PHYSIOLOGY, 1989, 51 :367-384

[3] Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats [J].

Briede, J ;

Stivrina, M ;

Stoldere, D ;

Bisenieks, E ;

Uldrikis, J ;

Poikans, J ;

Makarova, N ;

Duburs, G .

CELL BIOCHEMISTRY AND FUNCTION, 2004, 22 (04) :219-224

[4] Microwave-assisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: Novel compounds against aspergillosis [J].

Chhillar, AK ;

Arya, P ;

Mukherjee, C ;

Kumar, P ;

Yadav, Y ;

Sharma, AK ;

Yadav, V ;

Gupta, J ;

Dabur, R ;

Jha, HN ;

Watterson, AC ;

Parmar, VS ;

Prasad, AK ;

Sharma, GL .

BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) :973-981

[5] Impact of Novel MDR Modulators on Human Cancer Cells: Reversal Activities and Induction Studies [J].

Coburger, Claudius ;

Lage, Hermann ;

Molnar, Josef ;

Hilgeroth, Andreas .

PHARMACEUTICAL RESEARCH, 2009, 26 (01) :182-188

[6] 1,4-DIHYDROPYRIDINE ANTAGONIST ACTIVITIES AT THE CALCIUM-CHANNEL - A QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP APPROACH [J].

COBURN, RA ;

WIERZBA, M ;

SUTO, MJ ;

SOLO, AJ ;

TRIGGLE, AM ;

TRIGGLE, DJ .

JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (11) :2103-2107

[7] Characterizing the 1,4-dihydropyridines binding interactions in the L-type Ca2+ channel:: Model construction and docking calculations [J].

Cosconati, Sandro ;

Marinelli, Luciana ;

Lavecchia, Antonio ;

Novellino, Ettore .

JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1504-1513

[8] IMIDAZOL-1-YL AND PYRIDIN-3-YL DERIVATIVES OF 4-PHENYL-1,4-DIHYDROPYRIDINES COMBINING CA2+ ANTAGONISM AND THROMBOXANE-A(2) SYNTHASE INHIBITION [J].

COZZI, P ;

CARGANICO, G ;

FUSAR, D ;

GROSSONI, M ;

MENICHINCHERI, M ;

PINCIROLI, V ;

TONANI, R ;

VAGHI, F ;

SALVATI, P .

JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (20) :2964-2972

[9] SYNTHESIS AND CALCIUM-CHANNEL ANTAGONIST ACTIVITY OF DIALKYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(PYRIDINYL)-3,5-PYRIDINEDICARBOXYLATES [J].

DAGNINO, L ;

LIKWONGKEN, MC ;

WOLOWYK, MW ;

WYNN, H ;

TRIGGLE, CR ;

KNAUS, EE .

JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (12) :2524-2529

[10] Inhibition of type A GABA receptors by L-type calcium channel blockers [J].

Das, P ;

Bell-Horner, CL ;

Huang, RQ ;

Raut, A ;

Gonzales, EB ;

Chen, ZL ;

Covey, DF ;

Dillon, GH .

NEUROSCIENCE, 2004, 124 (01) :195-206

← 1 2 3 4 5 6 7 8 9 →